Mingfeng Yu - Concepedia

Author

Mingfeng Yu

University of South Australia ORCID

Also Known As

Mingfeng Yu, Yu, Mingfeng

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University of South Australia The University of Sydney Centre for Cancer Biology The University of Adelaide University of Potsdam

About

Mingfeng Yu is an author at University of South Australia specializing in medicine, pharmacology, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	396
2	Natural Sciences	8	8	223
3	Biochemistry	5	5	137
4	Biomolecular Engineering	4	4	141
5	Engineering	3	3	73

Mingfeng Yu

Publications

892

Citations

H-Index

Page 1

	Year	Citations
Discovery of 5‐(2‐(Phenylamino)pyrimidin‐4‐yl)thiazol‐2(3<i>H</i>)‐one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation Sarah Diab, Theodosia Teo, Malika Kumarasiri, ChemMedChem	2014	80
Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-<i>N</i>-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and Evaluation Solomon Tadesse, Mingfeng Yu, Laychiluh Mekonnen, Journal of Medicinal Chemistry Chemoprevention StrategyPharmacotherapyCell CyclePharmaceutical ChemistryTumor Biology	2017	68
Targeting CDK9 for treatment of colorectal cancer Muhammed H. Rahaman, Frankie Lam, Long‐Jin Zhong, Molecular Oncology	2019	56
Nontoxic Metal–Cyclam Complexes, a New Class of Compounds with Potency against Drug-Resistant <i>Mycobacterium tuberculosis</i> Mingfeng Yu, Gayathri Nagalingam, Samantha Ellis, Journal of Medicinal Chemistry ImmunologyPharmacotherapyChemistryDrug ResistanceMedicinal Chemistry	2016	50
Pharmacologic co-inhibition of Mnks and mTORC1 synergistically suppresses proliferation and perturbs cell cycle progression in blast crisis-chronic myeloid leukemia cells Theodosia Teo, Mingfeng Yu, Yuchao Yang, Cancer Letters Hematological MalignancyPharmacologic Co-inhibitionMixed-phenotype Acute LeukemiaTumor SuppressorRadiation Oncology	2014	43
Clinical and CT Radiomics Nomogram for Preoperative Differentiation of Pulmonary Adenocarcinoma From Tuberculoma in Solitary Solid Nodule Yaoyao Zhuo, Yi Zhan, Zhiyong Zhang, Frontiers in Oncology	2021	37
Discovery of (<i>E</i>)-3-((Styrylsulfonyl)methyl)pyridine and (<i>E</i>)-2-((Styrylsulfonyl)methyl)pyridine Derivatives as Anticancer Agents: Synthesis, Structure–Activity Relationships, and Biological Activities Tiangong Lu, Aik Wye Goh, Mingfeng Yu, Journal of Medicinal Chemistry Anticancer AgentsStructure–activity RelationshipsChemical DerivativePharmaceutical ChemistryMedicinal Chemistry	2014	36
Copper, Nickel, and Zinc Cyclam–Amino Acid and Cyclam–Peptide Complexes May Be Synthesized with “Click” Chemistry and Are Noncytotoxic Mingfeng Yu, Jason R. Price∥, Paul R. Jensen, Inorganic Chemistry	2011	35
Efficient deprotection of <i>F</i>-BODIPY derivatives: removal of BF<sub>2</sub> using Brønsted acids Mingfeng Yu, Joseph K. Wong, Cyril Tang, Beilstein Journal of Organic Chemistry Chemical EngineeringBf2 MoietyDerivativesEngineeringDerivative (Chemistry)	2015	34
Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure–activity relationship analysis and biological evaluation Mingfeng Yu, Peng Li, Sunita K. C. Basnet, European Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ChemistryBiochemistryNatural SciencesDrug Discovery	2015	34

Page 1